SCHEMBL1460360

SCHEMBL1460360

OC(CN1CCOCC1)c1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.71
KMT2A Q03164 5/20 0.68
MEN1 O00255 4/20 0.68
GAA P10253 1/20 0.65
OPRM1 P35372 1/20 0.63
OPRD1 P41143 1/20 0.63
POLB P06746 1/20 0.61
IGF1R P08069 2/20 0.55
HSD17B10 Q99714 1/20 0.55
ATM Q13315 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23610052 1.00 KDM4E (0.71) KDM4EKMT2AMEN1GAAOPRM1
SCHEMBL17835877 1.00 KDM4E (0.71) KDM4EKMT2AMEN1GAAOPRM1
SCHEMBL2796836 0.87 GAA (0.82) KDM4EKMT2AMEN1GAAOPRM1
SCHEMBL10746494 0.87 GAA (0.82) KDM4EKMT2AMEN1GAAOPRM1
SCHEMBL1460325 0.85 MEN1 (0.57) KDM4EKMT2AMEN1GAAOPRM1
SCHEMBL31419975 0.84 KDM4E (0.73) KDM4EKMT2AMEN1GAAOPRM1
SCHEMBL1205842 0.83 GAA (0.71) KDM4EKMT2AMEN1GAAOPRM1
SCHEMBL3082979 0.83 GAA (0.71) KDM4EKMT2AMEN1GAAOPRM1
SCHEMBL6979453 0.83 GAA (0.71) KDM4EKMT2AMEN1GAAOPRM1
SCHEMBL13343050 0.83 HTR1A (0.62)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250179233-A1 PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF ALBEMARLE CORPORATION (US) 2025-06-05 US claimed
EP-4486808-A2 PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF ALBEMARLE CORPORATION (US) 2025-01-08 EP claimed
CN-119137172-A Process and catalyst for hydrogen-mediated anionic copolymerization of conjugated dienes and liquid copolymers thereof 雅宝公司 2024-12-13 CN claimed
WO-2023168218-A2 PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF ALBEMARLE CORPORATION (US) 2023-09-07 WO claimed
EP-3204453-B1 LOW MOLECULAR WEIGHT GRAFT POLYMER FOR SCALE INHIBITOR HERCULES LLC (US) 2019-08-28 EP claimed
US-9914790-B2 Low molecular weight graft polymer for scale inhibitor HERCULES LLC (US) 2018-03-13 US claimed
EP-3204453-A1 LOW MOLECULAR WEIGHT GRAFT POLYMER FOR SCALE INHIBITOR Hercules LLC (US) 2017-08-16 EP claimed
WO-2016057299-A1 LOW MOLECULAR WEIGHT GRAFT POLYMER FOR SCALE INHIBITOR HERCULES INCORPORATED (US) 2016-04-14 WO claimed
US-20160096908-A1 LOW MOLECULAR WEIGHT GRAFT POLYMER FOR SCALE INHIBITOR ISP INVESTMENTS LLC 2016-04-07 US claimed
US-20250179233-A1 PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF ALBEMARLE CORPORATION (US) 2025-06-05 US disclosed
EP-4486808-A2 PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF ALBEMARLE CORPORATION (US) 2025-01-08 EP disclosed
CN-119137172-A Process and catalyst for hydrogen-mediated anionic copolymerization of conjugated dienes and liquid copolymers thereof 雅宝公司 2024-12-13 CN disclosed
WO-2023168218-A2 PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF ALBEMARLE CORPORATION (US) 2023-09-07 WO disclosed
US-11130734-B2 Amino alcohol-boron-binol complex and method for preparing optically active amino alcohol derivative by using same MOLECULES & MATERIALS CO., LTD. (KR) 2021-09-28 US disclosed
EP-2475643-A1 NOVEL ETHANE DIAMINE HEPCIDIN ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2012-07-18 EP disclosed
WO-2011026959-A1 NOVEL ETHANE DIAMINE HEPCIDIN ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2011-03-10 WO disclosed
US-20110053941-A1 IDO Inhibitors NEWLINK GENETICS (US) 2011-03-03 US disclosed
CN-101932325-A Ido inhibitors NEWLINK GENETICS 2010-12-29 CN disclosed
EP-2227233-A2 IDO INHIBITORS Newlink Genetics (US) 2010-09-15 EP disclosed
WO-2009073620-A2 IDO INHIBITORS NEWLINK GENETICS (US) 2009-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130734-B2 Amino alcohol-boron-binol complex and method for preparing optically active amino alcohol derivative by using same BCAT1, BCAT2, HBS1L KDM4E 3777/4885KMT2A 3665/4885MEN1 924/4885
US-20110053941-A1 IDO Inhibitors IDO1, IDO2, INMT KDM4E 288/4885KMT2A 597/4885MEN1 2052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.